Splicing mutations in post-ET/post-PV myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:13 5 months ago 71 Скачать Далее
What's on the horizon for the treatment of MPNs? VJHemOnc – Video Journal of Hematology & HemOnc 1:19 5 months ago 37 Скачать Далее
The impact of anemia and transfusion dependence on patient QoL in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:30 9 months ago 167 Скачать Далее
The importance of symptom management in MPNs VJHemOnc – Video Journal of Hematology & HemOnc 1:52 1 year ago 80 Скачать Далее
Estimating transfusion-related medical costs & time burden in patients with MF in SIMPLIFY-1 VJHemOnc – Video Journal of Hematology & HemOnc 3:17 6 months ago 42 Скачать Далее
The need for disease-modifying agents in PV to prevent disease progression VJHemOnc – Video Journal of Hematology & HemOnc 1:25 1 year ago 53 Скачать Далее
MAIC of momelotinib versus fedratinib safety in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:52 9 months ago 73 Скачать Далее
Updates in MPNs from ASCO 2024: combination therapies, trial endpoints & future directions VJHemOnc – Video Journal of Hematology & HemOnc 2:28 2 days ago 69 Скачать Далее
An insight into how novel agents are influencing survival outcomes in patients with MF VJHemOnc – Video Journal of Hematology & HemOnc 3:54 1 year ago 100 Скачать Далее
Assessing & improving the symptoms of patients with MPNs VJHemOnc – Video Journal of Hematology & HemOnc 2:12 1 year ago 75 Скачать Далее
Add-on therapy with CK0804 for patients with MF who exhibit a suboptimal response to ruxolitinib VJHemOnc – Video Journal of Hematology & HemOnc 2:08 7 months ago 40 Скачать Далее
The role of NGS in improving diagnosis in MPNs VJHemOnc – Video Journal of Hematology & HemOnc 1:47 10 months ago 101 Скачать Далее
BET inhibition as a novel targeted therapy for myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 4:26 1 year ago 212 Скачать Далее
The importance of studying patient-reported outcomes in MPNs VJHemOnc – Video Journal of Hematology & HemOnc 1:46 1 year ago 32 Скачать Далее
Strategies to improve the efficacy of immunotherapy in indolent B-cell lymphomas VJHemOnc – Video Journal of Hematology & HemOnc 2:26 9 months ago 112 Скачать Далее
Genomic profiling at diagnosis of myeloid neoplasms VJHemOnc – Video Journal of Hematology & HemOnc 0:52 10 months ago 129 Скачать Далее
Indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:16 1 year ago 103 Скачать Далее
Safety and anemia outcomes with momelotinib vs pacritinib in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:20 1 year ago 282 Скачать Далее
The characteristics of patients with myelofibrosis taking ruxolitinib for 3 or more years VJHemOnc – Video Journal of Hematology & HemOnc 1:38 1 year ago 540 Скачать Далее
Promising agents under investigation in polycythemia vera VJHemOnc – Video Journal of Hematology & HemOnc 1:04 1 year ago 260 Скачать Далее
